This document summarizes key information about malignant bone tumors presented at a seminar. It discusses the most common primary malignant bone tumors including multiple myeloma, osteosarcoma, Ewing's sarcoma, chondrosarcoma, and others. For each tumor, it covers clinical presentation, pathology, imaging appearance, treatment options, and prognosis. Primary bone cancers are rare but can cause pain, swelling, and pathological fractures if not identified and treated early. Surgery, chemotherapy, and radiation are often used either alone or in combination depending on the specific bone tumor.
Malignant bone tumors- clinical presentation, epidemiology, pathological findings, radiological findings, cases
Includes osteosarcoma, Ewing's sarcoma, and chondrosarcoma in detail.
Malignant bone tumors- clinical presentation, epidemiology, pathological findings, radiological findings, cases
Includes osteosarcoma, Ewing's sarcoma, and chondrosarcoma in detail.
Supracondylar humerus fracture & complication for MBBS studentsYash Oza
Fracture classification, xray, complication, reduction method, surgery, cast, vascular injury, nerve injury, all the Undergraduate students should know is included
A brief introduction to the topic cerebral palsy, prepared by Dr Yash Oza, PG resident in MS Orthopaedics
Etiology, Classification, assessment, diagnosis, treatment
Title: Sense of Smell
Presenter: Dr. Faiza, Assistant Professor of Physiology
Qualifications:
MBBS (Best Graduate, AIMC Lahore)
FCPS Physiology
ICMT, CHPE, DHPE (STMU)
MPH (GC University, Faisalabad)
MBA (Virtual University of Pakistan)
Learning Objectives:
Describe the primary categories of smells and the concept of odor blindness.
Explain the structure and location of the olfactory membrane and mucosa, including the types and roles of cells involved in olfaction.
Describe the pathway and mechanisms of olfactory signal transmission from the olfactory receptors to the brain.
Illustrate the biochemical cascade triggered by odorant binding to olfactory receptors, including the role of G-proteins and second messengers in generating an action potential.
Identify different types of olfactory disorders such as anosmia, hyposmia, hyperosmia, and dysosmia, including their potential causes.
Key Topics:
Olfactory Genes:
3% of the human genome accounts for olfactory genes.
400 genes for odorant receptors.
Olfactory Membrane:
Located in the superior part of the nasal cavity.
Medially: Folds downward along the superior septum.
Laterally: Folds over the superior turbinate and upper surface of the middle turbinate.
Total surface area: 5-10 square centimeters.
Olfactory Mucosa:
Olfactory Cells: Bipolar nerve cells derived from the CNS (100 million), with 4-25 olfactory cilia per cell.
Sustentacular Cells: Produce mucus and maintain ionic and molecular environment.
Basal Cells: Replace worn-out olfactory cells with an average lifespan of 1-2 months.
Bowman’s Gland: Secretes mucus.
Stimulation of Olfactory Cells:
Odorant dissolves in mucus and attaches to receptors on olfactory cilia.
Involves a cascade effect through G-proteins and second messengers, leading to depolarization and action potential generation in the olfactory nerve.
Quality of a Good Odorant:
Small (3-20 Carbon atoms), volatile, water-soluble, and lipid-soluble.
Facilitated by odorant-binding proteins in mucus.
Membrane Potential and Action Potential:
Resting membrane potential: -55mV.
Action potential frequency in the olfactory nerve increases with odorant strength.
Adaptation Towards the Sense of Smell:
Rapid adaptation within the first second, with further slow adaptation.
Psychological adaptation greater than receptor adaptation, involving feedback inhibition from the central nervous system.
Primary Sensations of Smell:
Camphoraceous, Musky, Floral, Pepperminty, Ethereal, Pungent, Putrid.
Odor Detection Threshold:
Examples: Hydrogen sulfide (0.0005 ppm), Methyl-mercaptan (0.002 ppm).
Some toxic substances are odorless at lethal concentrations.
Characteristics of Smell:
Odor blindness for single substances due to lack of appropriate receptor protein.
Behavioral and emotional influences of smell.
Transmission of Olfactory Signals:
From olfactory cells to glomeruli in the olfactory bulb, involving lateral inhibition.
Primitive, less old, and new olfactory systems with different path
Flu Vaccine Alert in Bangalore Karnatakaaddon Scans
As flu season approaches, health officials in Bangalore, Karnataka, are urging residents to get their flu vaccinations. The seasonal flu, while common, can lead to severe health complications, particularly for vulnerable populations such as young children, the elderly, and those with underlying health conditions.
Dr. Vidisha Kumari, a leading epidemiologist in Bangalore, emphasizes the importance of getting vaccinated. "The flu vaccine is our best defense against the influenza virus. It not only protects individuals but also helps prevent the spread of the virus in our communities," he says.
This year, the flu season is expected to coincide with a potential increase in other respiratory illnesses. The Karnataka Health Department has launched an awareness campaign highlighting the significance of flu vaccinations. They have set up multiple vaccination centers across Bangalore, making it convenient for residents to receive their shots.
To encourage widespread vaccination, the government is also collaborating with local schools, workplaces, and community centers to facilitate vaccination drives. Special attention is being given to ensuring that the vaccine is accessible to all, including marginalized communities who may have limited access to healthcare.
Residents are reminded that the flu vaccine is safe and effective. Common side effects are mild and may include soreness at the injection site, mild fever, or muscle aches. These side effects are generally short-lived and far less severe than the flu itself.
Healthcare providers are also stressing the importance of continuing COVID-19 precautions. Wearing masks, practicing good hand hygiene, and maintaining social distancing are still crucial, especially in crowded places.
Protect yourself and your loved ones by getting vaccinated. Together, we can help keep Bangalore healthy and safe this flu season. For more information on vaccination centers and schedules, residents can visit the Karnataka Health Department’s official website or follow their social media pages.
Stay informed, stay safe, and get your flu shot today!
micro teaching on communication m.sc nursing.pdfAnurag Sharma
Microteaching is a unique model of practice teaching. It is a viable instrument for the. desired change in the teaching behavior or the behavior potential which, in specified types of real. classroom situations, tends to facilitate the achievement of specified types of objectives.
Report Back from SGO 2024: What’s the Latest in Cervical Cancer?bkling
Are you curious about what’s new in cervical cancer research or unsure what the findings mean? Join Dr. Emily Ko, a gynecologic oncologist at Penn Medicine, to learn about the latest updates from the Society of Gynecologic Oncology (SGO) 2024 Annual Meeting on Women’s Cancer. Dr. Ko will discuss what the research presented at the conference means for you and answer your questions about the new developments.
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists Saeid Safari
Preoperative Management of Patients on GLP-1 Receptor Agonists like Ozempic and Semiglutide
ASA GUIDELINE
NYSORA Guideline
2 Case Reports of Gastric Ultrasound
Explore natural remedies for syphilis treatment in Singapore. Discover alternative therapies, herbal remedies, and lifestyle changes that may complement conventional treatments. Learn about holistic approaches to managing syphilis symptoms and supporting overall health.
New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...i3 Health
i3 Health is pleased to make the speaker slides from this activity available for use as a non-accredited self-study or teaching resource.
This slide deck presented by Dr. Kami Maddocks, Professor-Clinical in the Division of Hematology and
Associate Division Director for Ambulatory Operations
The Ohio State University Comprehensive Cancer Center, will provide insight into new directions in targeted therapeutic approaches for older adults with mantle cell lymphoma.
STATEMENT OF NEED
Mantle cell lymphoma (MCL) is a rare, aggressive B-cell non-Hodgkin lymphoma (NHL) accounting for 5% to 7% of all lymphomas. Its prognosis ranges from indolent disease that does not require treatment for years to very aggressive disease, which is associated with poor survival (Silkenstedt et al, 2021). Typically, MCL is diagnosed at advanced stage and in older patients who cannot tolerate intensive therapy (NCCN, 2022). Although recent advances have slightly increased remission rates, recurrence and relapse remain very common, leading to a median overall survival between 3 and 6 years (LLS, 2021). Though there are several effective options, progress is still needed towards establishing an accepted frontline approach for MCL (Castellino et al, 2022). Treatment selection and management of MCL are complicated by the heterogeneity of prognosis, advanced age and comorbidities of patients, and lack of an established standard approach for treatment, making it vital that clinicians be familiar with the latest research and advances in this area. In this activity chaired by Michael Wang, MD, Professor in the Department of Lymphoma & Myeloma at MD Anderson Cancer Center, expert faculty will discuss prognostic factors informing treatment, the promising results of recent trials in new therapeutic approaches, and the implications of treatment resistance in therapeutic selection for MCL.
Target Audience
Hematology/oncology fellows, attending faculty, and other health care professionals involved in the treatment of patients with mantle cell lymphoma (MCL).
Learning Objectives
1.) Identify clinical and biological prognostic factors that can guide treatment decision making for older adults with MCL
2.) Evaluate emerging data on targeted therapeutic approaches for treatment-naive and relapsed/refractory MCL and their applicability to older adults
3.) Assess mechanisms of resistance to targeted therapies for MCL and their implications for treatment selection
These simplified slides by Dr. Sidra Arshad present an overview of the non-respiratory functions of the respiratory tract.
Learning objectives:
1. Enlist the non-respiratory functions of the respiratory tract
2. Briefly explain how these functions are carried out
3. Discuss the significance of dead space
4. Differentiate between minute ventilation and alveolar ventilation
5. Describe the cough and sneeze reflexes
Study Resources:
1. Chapter 39, Guyton and Hall Textbook of Medical Physiology, 14th edition
2. Chapter 34, Ganong’s Review of Medical Physiology, 26th edition
3. Chapter 17, Human Physiology by Lauralee Sherwood, 9th edition
4. Non-respiratory functions of the lungs https://academic.oup.com/bjaed/article/13/3/98/278874
Tom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness Journeygreendigital
Tom Selleck, an enduring figure in Hollywood. has captivated audiences for decades with his rugged charm, iconic moustache. and memorable roles in television and film. From his breakout role as Thomas Magnum in Magnum P.I. to his current portrayal of Frank Reagan in Blue Bloods. Selleck's career has spanned over 50 years. But beyond his professional achievements. fans have often been curious about Tom Selleck Health. especially as he has aged in the public eye.
Follow us on: Pinterest
Introduction
Many have been interested in Tom Selleck health. not only because of his enduring presence on screen but also because of the challenges. and lifestyle choices he has faced and made over the years. This article delves into the various aspects of Tom Selleck health. exploring his fitness regimen, diet, mental health. and the challenges he has encountered as he ages. We'll look at how he maintains his well-being. the health issues he has faced, and his approach to ageing .
Early Life and Career
Childhood and Athletic Beginnings
Tom Selleck was born on January 29, 1945, in Detroit, Michigan, and grew up in Sherman Oaks, California. From an early age, he was involved in sports, particularly basketball. which played a significant role in his physical development. His athletic pursuits continued into college. where he attended the University of Southern California (USC) on a basketball scholarship. This early involvement in sports laid a strong foundation for his physical health and disciplined lifestyle.
Transition to Acting
Selleck's transition from an athlete to an actor came with its physical demands. His first significant role in "Magnum P.I." required him to perform various stunts and maintain a fit appearance. This role, which he played from 1980 to 1988. necessitated a rigorous fitness routine to meet the show's demands. setting the stage for his long-term commitment to health and wellness.
Fitness Regimen
Workout Routine
Tom Selleck health and fitness regimen has evolved. adapting to his changing roles and age. During his "Magnum, P.I." days. Selleck's workouts were intense and focused on building and maintaining muscle mass. His routine included weightlifting, cardiovascular exercises. and specific training for the stunts he performed on the show.
Selleck adjusted his fitness routine as he aged to suit his body's needs. Today, his workouts focus on maintaining flexibility, strength, and cardiovascular health. He incorporates low-impact exercises such as swimming, walking, and light weightlifting. This balanced approach helps him stay fit without putting undue strain on his joints and muscles.
Importance of Flexibility and Mobility
In recent years, Selleck has emphasized the importance of flexibility and mobility in his fitness regimen. Understanding the natural decline in muscle mass and joint flexibility with age. he includes stretching and yoga in his routine. These practices help prevent injuries, improve posture, and maintain mobilit
2. INTRODUCTION
• Primary bone tumors are very rare.
• Osteosarcoma, Ewing’s sarcoma and Fibrosarcoma are primary
malignant tumors of bone, they rarely present as multifocal disease.
• Multiple malignant lesion usually indicate metastatic disease
3. Clinical presentation
1. Painless bony mass (usually benign)
2. Painfull bony mass (usually malignant)
3. Soft tissue mass (feature of malignant and aggressive lesion)
4. Bone tumor as incidental finding
5. Pathological fracture
4. Classification of bone tumors
Type benign malignant
Bone forming
(osteogenic)
Osteoma,
Osteoblastoma
Osteosarcoma
Cartilage Forming
(Chondrogeic)
Chondroma,
Osteochondroma,
Chondromyxoid fibroma
Chondrosarcoma,
Clear cell chondroma,
Giant Cell Tumors Classical GCT Malignant GCT
Marrow Tumors Ewing Sarcoma
Reticulosarcoma
Lymphosarcoma
Myeloma
5. Type benign malignant
Vascular Tumors Heamangioma,
Lymphangioma,
Glomus Tumor
Angiosarcoma
Connective tissue Tumors Desmoplastic fibroma
Lipoma
Fibrosarcoma
Liposarcoma
Malignant
Mesenchymoma
Undifferentiated sarcoma
Other Tumors Chordoma, Adamantinoma, Neurilemmoma,
Neurofibroma
Tumor Like lesion Solitory Bone Cyst, Aneurysmal Bone cyst, Juxta-
Articular Bone cyst, Metaphilic fibrous defect,
Fibrous Dysplasia,Myosistis Ossificans, Brown Tumor
6. Common Malignant tumors of bone
1. Multiple Myeloma
2. Osteosarcoma
3. Ewing’s Sarcoma
4. Chondrosarcoma
5. Malignant GCT
6. Fibrosarcoma
7. Histiocytic Lymphoma
8. Liposarcoma
9. Adamantinoma
10. Chrodoma
7. 1. Multiple Myeloma
• Most common primary malignant bone tumor
• 40% of primary bone tumor
• Male : Female = 2:1
• Peak at 7th decade
• Etiology :
• Not known
• Commonly seen in farmers, wood workers, leather workers, and those
exposed to petroleum products
• Chromosomal abnormalities
8. • Pathogenesis :
• Plasma cell ( Terminally differentiated cell of B-cell lineage)
• Clonal neoplastic plasma cell transformation
• Over production of single antibody that appears in plasma (M-Protein)
• This clonal plasma cell activate osteoclasts by release of chemokines
• It is also associated with increased generation of osteoclast from
monocte precursors.
Skeletal Distribution :
Ribs, Skull, Pelvis, Long bones,Spine
In long bones : Metaphysis
In Spine : Body of vertabre
9. • Patho:
• Gross – Marrow is replaced by soft, gelatinous, radish grey or
fleshy white tissue
• Histo – Atypical Plasma cells replacing normal fatty &
hematopoietic marrow
10. • Clinical Features :
• Bone pain – dull aching, intermittent, mostly localized to lower
back, upper spine, pelvis, ribs, sternum
• Persistent pain indicates pathological fractures
• Bony lesion may expand and may be palpable ( especially on skull,
clavicle, sternum)
• Susceptibility to infection
• Renal Failure ( d/t Hypercalcemia, BJ Proteins, Amyloidosis)
• Anemia
• Clotting abnormalities
• Raynaud’s Phenomenon
• Hyper viscosity
• Constitutional symptoms
12. Xray in MM
• Generalized reduction in bone density
• Localized are of radiolucency
• Skull – Rain drop lesion, punched out, lytic lesion
• Marked bone expansion – “ballooned” appearance
• In spine – collapse of vertebral bodies, multiple level compression #
13.
14.
15.
16.
17. • Treatment
• Chemotherapy
• Bone marrow transplant
• Corticosteroids
• MELPHALAN ( Alkylating Agent)
• Plasmapheresis
• ORTHO:
• Treatment of impending or actual pathological fracture of spine, acetabulum,
proximal femur, proximal humerus
• ORIF with packing of cavities with bone cement
• Spine fractures needs stabilization
18. 2. OSTEOSARCOMA
• Highly malignant tumor
• Cell produces bone matrix
• Second most common primary malignant tumor of bone
• Male > Female
• Peak incident in 2nd decade
• Metaphysis of long bones
• Distal Femure > Prox Tibia > Prox Humerus
• Etiology
• Virus : polyoma virus, sv40 virus
• Radiation
• Chemicals
19. • Clinical Features:
• Pain : predominant symptom
• Swelling : Tender, Large (>5cm) mass. Skin over the swelling is
stretched ,shiny with dilated veins. Local rise in Temp. Consistency
variable
• Restriction of ROM
• Pathological #
• Edema distal to the lesion – d/t compression of venous/lymphatics
• Constitutional symptoms
20. • PATHO
• Gross –
• tumors violates cortex
• Associated soft tissue mass
• Variable consistency
• Yellow-brown to white
• Necrotic cysts
• Tumor may extend into medullary cavity also
• Histo-
• Hypercellular , cytological atypia, osteoid matrix, multinucleated giant cells
21. X ray
• Lytic, Blastic or Mixed bone destruction and production
• Soft tissue extension is the rule
• “Osteoblastic” Lesion – upper shaft and metaphysis are filled with
dense, amorphous, neoplastic bone.
• Codman’s Triangle – triangle of subperiosteal new bone formation
occurs at the upper and lower angles
• Sun-burst Appearance – spicules of neoplastic bone at right angle to
the long axis of bone ,along blood vessels elevated by periosteum.
27. • Surgeries
1. Local Resection ( Limb Sparing Sx)
Enblock removal of all previous biopsy site and all potential
contaminated tissue
2. Amputation
Generally done procedure for osteosarcoma
29. 3. EWING’S SARCOMA
• Neuroectodermal origin
• Male > Female
• 5yr and 25 yrs
• 95% of pt have t(11:22)(q24;q12) or t(21:22)(22:q12) translocations
• Family History
• Common sites
In long bones : Femur > Humerus > Tibia > Forearm bones
In Truncal Skeleton : Pelvis > Scapula > Vertebra > Ribs > Clavicle
30. • Location in long bones:
Mid Diaphysis – 33%
Meta- Diaphysis – 44%
Metaphysic – 15%
Meta Epiphysis – 6%
Epiphysis – 2%
• Size:
Range from 2 cm to 30 cm
Usually less than half of the bone length
31. • Clinial Features:
Pain : Mild & intermittent initially
Increase in severity over time
Swelling : Rapidly growing and painfull; tense,hard,elastic, tender,
Local rise in Temp.
There is period of remission with decreased size and exacerbation with
increased size of tumor over period of months to years
5% cases present with pathological #
Flue like symptoms
Death occurs d/t pulmonary involvement
32. • Xray
Diffuse rerefaction at center of shaft
Permiative diaphyseal tumor with mottled opacities
Onion layer formation
Bone destruction with pathological #
• Angiogram
Hypervascular reaction & Intrinsic neoplastic
vasculature
33. • Treatment
• Highly radiosensitive
• Chemotherapy
• Recurrence Common
• Chemo+Radio Combination brings down recurrence
• Surgery Indicated for
1. Expendable site
2. Lesion near major epiphysis
3. Failed radiation therapy
4. Large lesion with irreparable pathological #
De bulking of the tumor with limb preservation is done.
34. 4. CHONDROSARCOMA
• Malignant, slow growing, purely cartilage producing tumor
• Male > Female
• 20 to 60 yrs age group
• Location :
• Prox Humerus Shaft, Prox Femoral Shaft, Distal Femoral shaft, Pelvis, Ribs,
Scapula
• Antecedent Lesion
• Enchondroma, Osteochondroma, Paget’s Ds. , Synovial Chondromatosis
• Radiation is a risk factor
35. • PATHO:
• Gross- types
• Central Chondrosarcoma : Lobulated , Translucent, Bluish cartilaginous mass
within medullary cavity.
Endosteal aspect of cortex is eroded
Tumor contains yellow-white specks of calcification and occasional area of
mucoid cavities.
Tumor speads throughout medullary cavity
• Peripheral Chondrosarcoma : Pedicle origined from previously benign
exostosis
36. • Clinical Features:
• Pain & Swelling
• Central type remains asymptomatic until it erodes & penetrates the cortex
and cause pathological #
• Afterwards it present as swelling over affected bone. Pain is not prominent
feature
• Neurological Involvement
• Being asymptomatic it is ignored initially and pelvic tumors may present with
dysfunction of sciatic, femoral or lumbosacral plexus.
37. • X ray
• Extension of medullary portion of bone
• Thickening of cortex
• Different types of calcification
• Popcorn like
• Comma shaped
• Arc like
• Annular type
38. • Treatment – Surgical
• Local wide excision with reconstructive procedure
• Arthrodesis of knee reserved for vigorous young adults
• TKR
• Above Knee amputation for elderly patients
39. 5.MALIGNANT GCT
• Malignant giant cell tumor is extremely rare
• Most cases actually represents another type of malignancy arising
within GCT
• McGrath divided Malignant GCT in 3 types
1. Primary : GCT malignant from onset
2. Evolutionary : Malignant transformation after multiple resection or
after long latency period
3. Secondary : Develops after radiation therapy
• Diagnosis : Histological
• Treatment : Wide Excision with reconstructive procedure
• Poor Prognosis
40. 6. FIBROSARCOMA
• Arise from Fibrous layer of periosteum
• Age : over 30yrs
• Site : Long Bones (Most common- Femur), Ribs, Skull, Vertebrae,
mandible
• Position : Subperiosteal area of diaphysis or metaphysis
• Clinical Feature :
• Pain & Swelling – Gradually increasing, Smooth,Firm,Rubbery
textured swelling
• Tumor infiltrates overlying soft tissue and ROM is restricted
• Pathological #
41. • Xray
• Soft tissue shadow denser than muscles
• Single, Extra-osseous, Adjacent to cortex,
• Beneath the tumor there is saucer shaped cortical erosion of varying
depth
42. • Gross Appearance –
• Well encapsulated, firm, white, fibrous, glistering mass beneath the
periosteum
• Treatment :
• Surgical - Amputation
43. 7. HISTIOCYTIC LYMPHOMA
• Arises from marrow reticular cells
• Age : 20-50yrs
• Site : Long Bones
• Position : In Medulla, Epiphysis or metaphysis
• Clinical Features
• Insidious onset pain ( Mild to Moderate – Never Severe )
• Soft Swelling
• No Fever
• Pathological #
44. • Xray –
• Area of decreased density appears in medulla which spreads to
cortex and then invades soft tissue
45. • Gross appearance
• Grayish , soft to firm
• Vascular with small areas of hemorrhage
• Treatment :
• Radiotherapy if tumor is unifocal
• Multifocal : Chemo + Radio therapy
46. 8.LIPOSARCOMA
• Resembles FIBROSARCOMA in appearance but histologically it shows
origin from fat cells
• Site : Long Bones
• Position : Metaphysis , Epiphysis
Gross Appearance : Soft grayish yellow, lobulated mass
Treatment :
Tumor is Radiosensitive
En block resection with chemotherapy
Amputation suggested if massive wound contamination
47. 9. ADAMANTINOMA
• Also called ameloblastoma.
• Histologically resembles benign but is local invasive.
• Arise from odontogenic epithelium embedded in fibrous stroma.
• Age : 10-35 yrs
• Site : Long Bones ( Tibia Most Common)
• Tumor is slowly progressive and locally invasive. It rarely metastases.
• Pain, swelling, tenderness And Pathological # are presenting
symptoms.
48. • Gross Appearance :
• Yellow, Gray to grayish white, flesfy or firm
• Treatment :
• En Block Excision
• If Recurrence after en block excision then - Amputation
49. 10. CHORDOMA
• Rare neoplasm of cranium and spine.
• Derived from embryological remenant of notochord.
• Site : Skull ( Spheno-Occipital region) , Sacrococcygeal region
• Clinical Features :
• Pain : First it occurs in anal and rectal region. Mild & Intermittent
• Constipation & Urinary difficulty
• Motor and sensory disturbance in lower limb may occur in late stage
• Swelling : Over posterior of anterior aspect of sacrum. Tender, soft,
fixed.
50.
51. • Xray
• Well Circumscribed osteolytic expansile defect over lower sacrum
• Rounded soft tissue shadow extends anteriorly of posteriorly.
• If vertebrae involved their arches are collapsed
52. • Treatment :
• Radiotherapy – only use full in children
• Surgery – Wide excision – Recurrence is common